Medications
Neurology
Neurology
Alzheimer’s Disease Agents
| Donepezil | ARICEPT |
| Galantamine | RAZADYNE |
| Memantine | NAMENDA |
| Rivastigmine | EXELON |
D – diagnosis may dictate restriction
Anticonvulsants
| Carbamazepine | TEGRETOL |
T – temporary restriction at beginning of treatment; monitor for sedation, behavior changes, ataxia, visual disturbances
D – diagnosis may dictate restriction
| Ethosuximide | ZARONTIN |
| Felbamate | FELBATOL |
T – temporary restriction at beginning of treatment; monitor for sedation, dizziness, ataxia, behavior changes
D – diagnosis may dictate restriction
| Fosphenytoin | CEREBYX |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation, hypotension
D – diagnosis may dictate restriction
| Gabapentin | NEURONTIN |
| Lamotrigine | LAMICTAL |
T – temporary restriction at beginning of treatment; monitor for sedation, dizziness, ataxia, behavior changes
D – diagnosis may dictate restriction
| Levetiracetam | KEPPRA |
T – temporary restriction at beginning of treatment; monitor for sedation, ataxia, behavior changes
D – diagnosis may dictate restriction
| Oxcarbazepine | TRILEPTAL |
T – temporary restriction at beginning of treatment; monitor for sedation, dizziness, ataxia, visual disturbances
D – diagnosis may dictate restriction
| Phenobarbital |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
| Phenytoin | DILANTIN |
T – temporary restriction at beginning of treatment; monitor for dizziness, ataxia, behavior changes
D – diagnosis may dictate restriction
| Pregabalin | LYRICA |
T – temporary restriction at beginning of treatment; monitor for sedation, dizziness, ataxia, behavior changes, visual disturbances
D – diagnosis may dictate restriction
| Primidone | MYSOLINE |
T – temporary restriction at beginning of treatment; monitor for sedation, ataxia, behavior changes, visual disturbances
D – diagnosis may dictate restriction
| Tiagabine | GABITRIL |
T – temporary restriction at beginning of treatment; monitor for sedation, dizziness, tremor, ataxia, behavior changes
D – diagnosis may dictate restriction
| Topiramate | TOPAMAX |
T – temporary restriction at beginning of treatment; monitor for behavior changes, visual disturbances, sedation
D – diagnosis may dictate restriction
| Valproic acid | DEPAKOTE |
T – temporary restriction at beginning of treatment; monitor for behavior changes, sedation
D – diagnosis may dictate restriction
| Zonisamide | ZONEGRAN |
T – temporary restriction at beginning of treatment; monitor for sedation, dizziness, ataxia, behavior changes, visual disturbances
D – diagnosis may dictate restriction
Antimigraine Agents – Triptans
| Almotriptan | AXERT |
| Eletriptan | RELPAX |
| Frovatriptan | FROVA |
| Naratriptan | AMERGE |
| Rizatriptan | MAXALT |
| Zolmitriptan | ZOMIG |
| Sumatriptan | IMITREX |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
Antimigraine Agents – Other
| Acetaminophen and butalbital and caffeine | FIORICET |
| Aspirin and butalbital and caffeine | FIORINAL |
| Dihydroergotamine | MIGRANAL |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
| Ergotamine and caffeine | CAFERGOT |
A – approved while on duty
| Isometheptene and dichloralphenazone and acetaminophen | MIDRIN |
A – approved while on duty; monitor for dizziness
Antimyasthenic Agents
| Edrophonium | TENSILON |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of arrhythmia and hypotension
D – diagnosis may dictate restriction
| Neostigmine | PROSTIGMIN |
| Pyridostigmine | MESTINON |
A – approved if taken off duty
D – diagnosis may dictate restriction
Antiparkinson Agents
| Amantadine | SYMMETREL |
| Apomorphine | |
| Benztropine mesylate | COGENTIN |
| Biperiden | |
| Bromocriptine | PARLODEL |
| Carbidopa | |
| Carbidopa and levodopa | SINEMET |
| Entacapone | |
| Pergolide | PERMAX |
| Pramipexole | MIRAPEX |
| Ropinirole | REQUIP |
| Tolcapone | |
| Trihexiphenidyl | ARTANE |
T – temporary restriction at beginning of treatment; monitor for dizziness, sedation, orthostatic hypotension, behavior changes
D – diagnosis may dictate restriction
Other Neurologic Agents
| Glatiramer | COPAXONE |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of injection site reactions
D – diagnosis may dictate restriction
| Interferon beta 1a | AVONEX |
T – temporary restriction at beginning of treatment; monitor for behavior changes, dizziness, visual disturbances
D – diagnosis may dictate restriction
| Interferon beta 1b | BETASERON |
T – temporary restriction at beginning of treatment; monitor for behavior changes, dizziness
D – diagnosis may dictate restriction
| Nimodipine | NIMOTOP |
D – diagnosis may dictate restriction
| Oxybate | XYREM |
T – temporary restriction at beginning of treatment; monitor for behavior changes, sedation
D – diagnosis may dictate restriction
| Riluzole | RILUTEK |
D – diagnosis may dictate restriction